Latest filing published 07 Apr 2026 for Core Laboratories Inc. /DE/. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
This profile gathers the share dealings of Harvey Robert Klingensmith across 2 companies, led by Core Laboratories Inc. /DE/ and Core Laboratories N V. The record holds 5 filings, for trades running from 1 April 2022 to 1 April 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 7 April 2026 came the latest disclosure, an option exercise in Core Laboratories Inc. /DE/. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations